238 related articles for article (PubMed ID: 10821971)
1. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
Kurane I; Takasaki T
Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
[TBL] [Abstract][Full Text] [Related]
2. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
Wu CJ; Huang HW; Tao MH
Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
[TBL] [Abstract][Full Text] [Related]
3. Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus.
Okuno Y; Okamoto Y; Yamada A; Baba K; Yabuuchi H
Vaccine; 1987 Jun; 5(2):128-32. PubMed ID: 3037813
[TBL] [Abstract][Full Text] [Related]
4. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
5. Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
Yun KW; Lee HJ; Park JY; Cho HK; Kim YJ; Kim KH; Kim NH; Hong YJ; Kim DH; Kim HM; Cha SH
Vaccine; 2018 Mar; 36(11):1398-1404. PubMed ID: 29429815
[TBL] [Abstract][Full Text] [Related]
6. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Clin Infect Dis; 2013 Jan; 56(2):267-70. PubMed ID: 23074319
[TBL] [Abstract][Full Text] [Related]
7. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086
[TBL] [Abstract][Full Text] [Related]
8. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.
Chanthavanich P; Limkittikul K; Sirivichayakul C; Chokejindachai W; Hattasingh W; Pengsaa K; Surangsrirat S; Srisuwannaporn T; Kaewma B; Yoksan S; Jun G; Zhumu B
Hum Vaccin Immunother; 2018 Apr; 14(4):900-905. PubMed ID: 29227177
[TBL] [Abstract][Full Text] [Related]
10. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
11. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
13. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
Gowal D; Tahlan AK
Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
[TBL] [Abstract][Full Text] [Related]
16. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
Ferguson M; Johnes S; Li L; Heath A; Barrett A
Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
[TBL] [Abstract][Full Text] [Related]
17. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
18. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.
Aihara H; Takasaki T; Toyosaki-Maeda T; Suzuki R; Okuno Y; Kurane I
Viral Immunol; 2000; 13(2):179-86. PubMed ID: 10892998
[TBL] [Abstract][Full Text] [Related]
19. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
20. Assessment of neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan.
Shyu WR; Wang YC; Chin C; Chen WJ
Epidemiol Infect; 1997 Aug; 119(1):79-83. PubMed ID: 9287947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
